| Previous close | 0.0400 |
| Open | 0.0100 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 50.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.0100 - 0.0400 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Investing.com
ProPicks: Beat the S&P 500 with our cutting-edge AI-powered stock selection
Sign up now to see all the the picks and follow the 'Beat the S&P 500' strategy for up to 60% off for a limited time only!
Motley FoolIs Pfizer Stock a Buy Now?
Pfizer (NYSE: PFE), known for its billion-dollar coronavirus products -- the vaccine Comirnaty and the treatment Paxlovid -- saw its shares drop about 40%. This includes Pfizer's newer programs and what they may deliver in the future, as well as the company's valuation today. Is Pfizer a buy right now -- or a stock to avoid?
Motley FoolWhy I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
One stock I'm considering letting go is pharma giant Pfizer (NYSE: PFE). Here are two other issues driving me toward hitting the "sell" button on this pharma stock. Since Albert Bourla took over as CEO in 2019, Pfizer has been on a buying spree.
© 2023 Yahoo. All rights reserved.